Pharmacist-led HFrEF medication optimization for Heart Failure with Reduced Ejection Fraction
Study Summary
This trial will test if a remote pharmacist-led intervention can improve medication use in people with HFrEF.
- Heart Failure with Reduced Ejection Fraction
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 6 Secondary · Reporting Duration: month 12
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Pharmacist-led HFrEF medication optimization
1 of 1
Experimental Treatment
60 Total Participants · 1 Treatment Group
Primary Treatment: Pharmacist-led HFrEF medication optimization · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are medical professionals currently accepting participants for this trial?
"As per clinicaltrials.gov, this investigation is still looking to enrol participants. The trial was established on March 13th 2023 and amended most recently on the 9th of that same month." - Anonymous Online Contributor
What is the total number of volunteers taking part in this experiment?
"Affirmative. According to clinicaltrials.gov, this research is currently recruiting patients who meet its inclusion criteria. The initial posting date was March 13th 2023 and the listing has been up-to-date as of March 9th 2023. 60 volunteers are being sought from a single trial site." - Anonymous Online Contributor